AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2025
Jul 30, 2025
31949_dirs_2025-07-30_3bf23bbc-a010-4f22-9d4b-511da1ae3532.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2025-07-29
Reporting Person: Brackmann Christoph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-29 | Ordinary Shares | P | 10000.00 | $11.63 | Acquired | 131150.00 | Direct |
| 2025-07-29 | Ordinary Shares | P | 5000.00 | $11.60 | Acquired | 136150.00 | Direct |
| 2025-07-29 | Ordinary Shares | P | 5000.00 | $11.50 | Acquired | 141150.00 | Direct |
More from NovoCure Ltd
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Proxy Solicitation & Information Statement
2026
May 21
Earnings Release
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Board/Management Information
2026
Apr 24
Board/Management Information
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3